Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy

American Journal of Cardiology

Volumn 80, Issue 12, 1997, Pages 1566-1571

  Lip, Gregory Y H ^a   Blann, Andrew D ^a   Jones, Alan F ^a   Lip, Peck Lin ^a   Beevers, D Gareth ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CORONARY RISK; ENDOTHELIUM CELL; ETHNIC GROUP; FEMALE; FIBRINOLYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BLOOD PRESSURE; BLOOD VISCOSITY; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMATOCRIT; HEMOGLOBINS; HEMORHEOLOGY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INDIA; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; P-SELECTIN; PLASMINOGEN INACTIVATORS; RISK FACTORS; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 0031449649     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00749-2     Document Type: Article

References (28)

1. Lip GYH. Fibrinogen and cardiovascular disease. Quart J Med. 88:1995;155-165.
2. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor a meta-analysis and review of the literature . Ann Intern Med. 118:1993;956-963.
3. Lip GYH, Lowe GDO. Fibrin D-dimer A useful clinical marker of thrombogenesis? Clin Sci. 89:1995;205-214.
4. Hamsten A, de Falre U, Walldius G, Dahleń G, Szamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma risk factor for recurrent myocardial infarction . Lancet. 2:1987;3-8.
5. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med. 239:1996;17-34.
6. Lip GYH, Blann AD. von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J. 74:1995;580-583.
7. Lip GYH, Jones AF. Lipoprotein (a) and vascular disease thrombogenesis and atherogenesis . Quart J Med. 88:1995;529-539.
8. Taylor JO, Borhani NO, Entwisle G, Farber N, Hawkins CM. Hypertension detection and followup program. Summary of baseline characteristics of the hypertensive participants. Hypertension. 5:(suppl IV):1983;IV44-IV50.
9. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JM. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 7:1986;639-650.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
11. Lip GYH, Beevers DG. Abnormalities of rheology and coagulation in hypertension. J Hum Hypertens. 8:1994;693-702.
12. Leschke M, Motz W, Blanke H, Strauer BE. Blood rheology in hypertension and hypertensive heart disease. J Cardiovasc Pharmacol. 10:(suppl 6):1987;S103-S110.
13. Koenig W, Sund M, ErnstE Keil U, Rosenthal J, Hombach V. Association between plasma viscosity and blood pressure. Results from the MONICA-Project Augsburg. Am J Hypertens. 4:1991;529-536.
14. Smith WCS, Lowe GDO, Lee AJ, Tunstall-Pedoe H. Rheological determinents of blood pressure in a Scottish adult population. J Hypertension. 10:1992;467-472.
15. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma a novel risk factor for recurrent myocardial infarction and death . Br Heart J. 66:1991;351-355.
16. Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 332:1995;635-641.
17. Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA, MacGregor IR, Dawes J. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet. 342:1993;84-86.
18. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentrations of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 90:1994;2236-2240.
19. Lowe GDO, Rumley A, Yarnell JWG, Sweetnam PM, Thomas HF. Fibrin D-dimer, von Willebrand factor and tissue plasminogen activator antigens are predictors of major ischaemic heart disease the Caerphilly study . Blood Coag Fibrin. 6:1995;156-157.
20. Rowbotham BJ, Whitaker AN, Harrison J, Murtaugh P, Reasbeck P, Bowie EJW. Measurement of cross-linked fibrin derivatives in patients undergoing abdominal surgery use in the diagnosis of postoperative venous thrombosis . Blood Coag Fibrin. 3:1992;25-31.
21. Johnson Tidey RR McGregor JL, Taylor PR, Poston RN. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques coexpression with intercellular adhesion molecule-1 . Am J Pathol. 144:1994;952-961.
22. Blann AD, Lip GYH. Is soluble P-selectin a new marker of platelet activation? Atherosclerosis. 128:1997;135-138.
23. Ikeda H, Nakayama H, Oda T, Kuwano K, Muraishi A, Sugi K, Koga Y, Toshima H. Soluble form of P-selectin in patients with acute myocardial infarction. Coron Art Dis. 5:1994;515-518.
24. Lip GYH, Zarifis J, Blann AD, Farooqi IS, Sagar G, Beevers DG. Soluble adhesion molecule P selectin, von Willebrand factor and fibrinogen in acute stroke evidence for early endothelial and haemorheological dysfunction . The West Birmingham Stroke Project (abstr). J Am Coll Cardiol. 27:(suppl A):1996;35A-36A.
25. Donders SH, Lustermans FAT, Van Wersch JWJ. Low order correlations of lipoprotein (a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients. Blood Coag Fibrin. 3:1992;249-256.
26. Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med. 227:1990;273-278.
27. van Wersch JW, Rompelberg-Lahaye J, Lustermans FA. Plasma concentrations of coagulation and fibrinolysis factors and platelet function in hypertension. Eur J Clin Chem Clin Biochem. 29:1991;375-379.
28. Cruickshank JK, Beevers DG, Osbourne VL, Haynes RA, Corlett JCR, Selby S. Heart attack, stroke, diabetes and hypertension in West Indians, Asians and Whites in Birmingham, England. Br Med J. 281:1980;1108.